LifeStance Health (LFST) Equity Ratio (2021 - 2025)
LifeStance Health (LFST) has disclosed Equity Ratio for 5 consecutive years, with 0.69 as the latest value for Q4 2025.
- On a quarterly basis, Equity Ratio rose 1.08% to 0.69 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.69, a 1.08% increase, with the full-year FY2025 number at 0.69, up 1.08% from a year prior.
- Equity Ratio was 0.69 for Q4 2025 at LifeStance Health, down from 0.69 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.81 in Q2 2021 to a low of 0.67 in Q3 2023.
- A 5-year average of 0.72 and a median of 0.69 in 2025 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: dropped 13.53% in 2023, then grew 2.05% in 2025.
- LifeStance Health's Equity Ratio stood at 0.8 in 2021, then fell by 12.86% to 0.7 in 2022, then dropped by 3.06% to 0.68 in 2023, then grew by 0.82% to 0.68 in 2024, then rose by 1.08% to 0.69 in 2025.
- Per Business Quant, the three most recent readings for LFST's Equity Ratio are 0.69 (Q4 2025), 0.69 (Q3 2025), and 0.69 (Q2 2025).